Ongoing research from our group, presented at Breaking Convention 2019: https://www.youtube.com/watch?v=URSqxFocaas 5-methoxy-N,N-dimethyltryptamine (5-MeO-DMT) is a psychotropic substance found in various plant as well as animal species, and can also be synthetically produced. Despite the use of 5-MeO-DMT by people in naturalistic settings, current scientific knowledge on the effects of 5-MeO-DMT in humans are relatively… Continue reading Prospective Examination of Synthetic 5-methoxy-N,N-dimethyltryptamine Inhalation
Ongoing research from our group, presented at Breaking Convention 2019: https://www.youtube.com/watch?v=KEGJWxH-jYs Creative thinking and empathy are crucial for everyday interactions and subjective well-being. This is emphasised by studies showing a reduction in these skills in populations where social interaction and subjective well-being is significantly compromised (e.g. depression). Anecdotal reports and recent studies suggest a single… Continue reading (Sub-)Acute Effects of Psilocybin on Creativity, Empathy and Satisfaction with Life
New research from our group, published in Neuropsychopharmacology: Following a double-blind, placebo-controlled, parallel group design, we utilized an ultra-high field multimodal brain imaging approach and demonstrated that psilocybin (0.17 mg/kg) induced region-dependent alterations in glutamate, which predicted distortions in the subjective experience of one’s self (ego dissolution). Whereas higher levels of medial prefrontal cortical glutamate were… Continue reading How Magic Mushrooms Might Dissolve the Ego Revealed
Dr. Kim Kuypers and Natasha Mason were invited to speak at and participate in an event in Helsinki, Finland, discussing research on the therapeutic potential and mechanisms of action of psilocybin and MDMA. The panel discussion has now been posted, and can be viewed here.
New study from our group assessed cognitive and subjective effects of a synthetic cannabinoid, JWH-018. Read coverage of the publication from Live Science.